About I Interni klinika; Vseobecna fakultni nemocnice
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at I Interni klinika; Vseobecna fakultni nemocnice
During the past decade, I Interni klinika; Vseobecna fakultni nemocnice conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
2010-04-30
2018-11-30
Completed
413
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma
2014-10-15
2021-10-21
Completed
331
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "I Interni klinika; Vseobecna fakultni nemocnice"
#1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at I Interni klinika; Vseobecna fakultni nemocnice
According to Clinical.Site data, the most researched conditions in "I Interni klinika; Vseobecna fakultni nemocnice" are
"Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials), "Familial Primary Pulmonary Hypertension" (2 trials), "Hypertension" (2 trials) and "Hypertension, Pulmonary" (2 trials). Many other conditions were trialed in "I Interni klinika; Vseobecna fakultni nemocnice" in a lesser frequency.
Clinical Trials Intervention Types at I Interni klinika; Vseobecna fakultni nemocnice
Most popular intervention types in "I Interni klinika; Vseobecna fakultni nemocnice" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Bendamustine" (2 trials), "Obinutuzumab" (2 trials), "Ralinepag" (2 trials), "Placebo" (1 trials) and "Polatuzumab vedotin (Liquid)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at I Interni klinika; Vseobecna fakultni nemocnice
The vast majority of trials in "I Interni klinika; Vseobecna fakultni nemocnice" are
4 trials for "All" genders.
Clinical Trials Status at I Interni klinika; Vseobecna fakultni nemocnice
Currently, there are NaN active trials in "I Interni klinika; Vseobecna fakultni nemocnice".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 2 completed trials in I Interni klinika; Vseobecna fakultni nemocnice,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in I Interni klinika; Vseobecna fakultni nemocnice, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".